EpiPen Class Action Lawsuit Filed Over Inflated Pricing
An EpiPen class action lawsuit claims Mylan illegally dominated the epinephrine injector market by paying illegal rebates to pharmacy benefit managers.
An EpiPen class action lawsuit claims Mylan illegally dominated the epinephrine injector market by paying illegal rebates to pharmacy benefit managers.
An EpiPen recall has been expanded to include injection devices sold in the U.S.
A recall of more than 80,000 EpiPens in Europe and Asia was announced following reports that the devices failed to deliver medication when used.